Roland Feifel

1.7k citations

36 papers · 1.3k indexed · h-index 21

Impact in

Organic Chemistry top 5%
- Synthesis and biological activity
Cellular and Molecular Neuroscience top 10%
- Neuropeptides and Animal Physiology
- Neuroscience and Neuropharmacology Research

Papers in

Equine 1
Molecular Biology 28
- Receptor Mechanisms and Signaling 12
- Melanoma and MAPK Pathways 11
- Ion channel regulation and function 5
- Protein Kinase Regulation and GTPase Signaling 4

Co-authors: Láśzló Révész E. Mutschler Thomas Buhl Günter Lambrecht Reinhold Tacke Carsten Strohmann Achim Schlapbach Peter Hiestand
Journals: Bioorganic & Medicinal Chemistry Letters (12 papers)European Journal of Pharmacology (7 papers)Journal of Medicinal Chemistry (3 papers)ACS Medicinal Chemistry Letters (2 papers)British Journal of Pharmacology (2 papers)
Partner nations: Switzerland Germany United States

In The Last Decade

Roland Feifel

36 papers receiving 1.3k citations

Peers

Countries citing papers authored by Roland Feifel

Since Specialization

Citations

This map shows the geographic impact of Roland Feifel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Feifel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Feifel more than expected).

Fields of papers citing papers by Roland Feifel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Feifel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Feifel. The network helps show where Roland Feifel may publish in the future.

Co-authors

The 25 scholars most cited alongside Roland Feifel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roland Feifel Line = papers co-authored together Roland Feifel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Design and synthesis of potent and orally active GPR4 antagonists with modulatory effects on nociception, inflammation, and angiogenesis Bioorganic & Medicinal Chemistry ·Wolfgang Miltz, Juraj Velcicky, Janet Dawson, Amanda Littlewood‐Evans, Marie‐Gabrielle Ludwig, Klaus Seuwen, Roland Feifel, Berndt Oberhauser, Arndt Meyer, Daniela Gabriel, Mark S. Nash, Pius Loetscher	2017	22
2	In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Achim Schlapbach, Reiner Aichholz, Roland Feifel, Stuart Hawtin, Richard Heng, Peter Hiestand, Wolfgang Jahnke, Guido Koch, M. Kroemer, Henrik Möbitz, Clemens Scheufler, Juraj Velcicky, Christine Huppertz	2010	23
3	In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Achim Schlapbach, Reiner Aichholz, Janet Dawson, Roland Feifel, Stuart Hawtin, Amanda Littlewood‐Evans, Guido Koch, M. Kroemer, Henrik Möbitz, Clemens Scheufler, Juraj Velcicky, Christine Huppertz	2010	27
4	The Role of Interstitial Macrophages in Nephropathy of Type 2 Diabetic db/db Mice American Journal Of Pathology ·Volha Ninichuk, Alexander G. Khandoga, Stephan Segerer, Pius Loetscher, Achim Schlapbach, Láśzló Révész, Roland Feifel, Andrej Khandoga, Fritz Krombach, Peter J. Nelson, Detlef Schlöndorff, Hans‐Joachim Anders	2007	81
5	Evaluation of protease‐activated receptor 2 in murine models of arthritis Arthritis & Rheumatism ·Nathalie Busso, Matthias Frasnelli, Roland Feifel, Bruno Cenni, Martin Steinhoff, Justin R. Hamilton, Alexander So	2006	55
6	A cassette-dosing approach for improvement of oral bioavailability of dual TACE/MMP inhibitors Bioorganic & Medicinal Chemistry Letters ·Philipp Janser, Ulf Neumann, Wolfgang Miltz, Roland Feifel, Thomas Buhl	2006	11
7	Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK Bioorganic & Medicinal Chemistry Letters ·Rudolf Waelchli, Birgit Bollbuck, Christian Bruns, Thomas Buhl, Jörg Eder, Roland Feifel, René Hersperger, Philipp Janser, Láśzló Révész, Hans‐Günter Zerwes, Achim Schlapbach	2005	121
8	Pyrazoloheteroaryls: Novel p38α MAP kinase inhibiting scaffolds with oral activity Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Ernst Blum, Franco E. Di Padova, Thomas Buhl, Roland Feifel, Hermann Gram, Peter Hiestand, Ute Manning, Ulf Neumann, Gerard Rucklin	2005	63
9	Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Birgit Bollbuck, Thomas Buhl, Joerg Eder, Ronald E. Esser, Roland Feifel, Richard Heng, Peter Hiestand, Benedicte Jachez-Demange, Pius Loetscher, Helmut Sparrer, Achim Schlapbach, Rudolf Waelchli	2005	24
10	Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Ernst Blum, Franco E. Di Padova, Thomas Buhl, Roland Feifel, Hermann Gram, Peter Hiestand, Ute Manning, Gerard Rucklin	2004	51
11	SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activity Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Ernst Blum, Franco E. Di Padova, Thomas Buhl, Roland Feifel, Hermann Gram, Peter Hiestand, Ute Manning, Gerard Rucklin	2004	26
12	SAR of 2,6-diamino-3,5-difluoropyridinyl substituted heterocycles as novel p38MAP kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Franco E. Di Padova, Thomas Buhl, Roland Feifel, Hermann Gram, Peter Hiestand, Ute Manning, Romain M. Wolf, Alfred Zimmerlin	2002	48
13	SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Láśzló Révész, Franco E. Di Padova, Thomas Buhl, Roland Feifel, Hermann Gram, Peter Hiestand, Ute Manning, Alfred Zimmerlin	2000	41
14	ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-α Immunology Letters ·Gerald Künstle, Marcel Leist, Stefan Uhlig, Láśzló Révész, Roland Feifel, Andrew MacKenzie, Albrecht Wendel	1997	113
15	Binding and functional properties of hexocyclium and sila‐hexocyclium derivatives to muscarinic receptor subtypes British Journal of Pharmacology ·Magalì Waelbroeck, J Camus, M. Tastenoy, Roland Feifel, E. Mutschler, Reinhold Tacke, Carsten Strohmann, Klaus Rafeiner, Jaap F. Rodrigues de Miranda, G. Lambrecht	1994	10
16	Stereoselective inhibition of muscarinic receptor subtypes by the enantiomers of hexahydro‐difenidol and acetylenic analogues British Journal of Pharmacology ·Roland Feifel, Monika Wagner-Röder, Carsten Strohmann, Reinhold Tacke, Magalì Waelbroeck, Jean Christophe, E. Mutschler, G. Lambrecht	1990	19
17	Stereoselectivity at muscarinic receptor subtypes: observations with the enantiomers of phenglutarimide Chirality ·Günter Lambrecht, Roland Feifel, E. Mutschler	1989	10
18	Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes European Journal of Pharmacology ·Günter Lambrecht, Roland Feifel, Monika Wagner-Röder, Carsten Strohmann, Harald Zilch, Reinhold Tacke, Magalì Waelbroeck, Jean Christophe, Hendrikus Boddeke, E. Mutschler	1989	90
19	p-fluoro-hexahydro-sila-difenidol: The first M2β-selective muscarinic antagonist European Journal of Pharmacology ·Günter Lambrecht, Roland Feifel, Bernhard Forth, Carsten Strohmann, Reinhold Tacke, E. Mutschler	1988	114
20	Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes European Journal of Pharmacology ·Günter Lambrecht, Roland Feifel, Ulrich Moser, Arne Jørgen Aasen, Magalì Waelbroeck, Jean Christophe, E. Mutschler	1988	34

About Roland Feifel

Roland Feifel is a scholar working on Equine, Molecular Biology, Organic Chemistry, Cellular and Molecular Neuroscience and Immunology and Allergy, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (12 papers), Melanoma and MAPK Pathways (11 papers), Synthesis and biological activity (11 papers), Neuropeptides and Animal Physiology (5 papers), Ion channel regulation and function (5 papers), Quinazolinone synthesis and applications (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Organic Chemistry (338 citations), Cellular and Molecular Neuroscience (206 citations), Molecular Biology (769 citations), Cancer Research (118 citations) and Immunology (155 citations). Roland Feifel has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Láśzló Révész, E. Mutschler, Thomas Buhl, Günter Lambrecht, Reinhold Tacke, Carsten Strohmann, Achim Schlapbach, Peter Hiestand, Franco E. Di Padova and Ute Manning. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, European Journal of Pharmacology, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact